Medical Device Manufacturing

In recent years, the medical device industry has grown steadily, driven by global technological advances, the digitization and incorporation of new technologies, the increasing demand by the population, placing the sector in a complete panorama of growth and development.

Today, different companies manufacture devices capable of measuring the heart rate, pressure, sugar levels and the general state of the patient's health in an easy and affordable way for the population. New information technologies allow real-time diagnostics and automate health measurements, reliably and at the patient's hand at home.

Aging populations, increasing prevalence of chronic diseases and rising health care costs are some of the factors that drive health care spending, not just in the United States, but in many other countries around the world. Developed and developing countries alike seek advanced technologies to improve patient outcomes while decreasing health care costs. U.S. medical device exports are highly competitive and offer an opportunity for the country’s medical device companies to increase sales, grow jobs and maintain their competitive advantage. Headquartered in Westport, Connecticut, BioSig Technologies is a leading medical device company that plays a vital role in the field of bioelectronic medicine. Based on BioSig’s unique enabling technology and core competency in signal processing, the company’s initial focus is on heart disease and the fast-growing electrophysiology device market.

Arrhythmia, a common cardiac condition, causes the heart to beat too quickly, too slowly, or erratically. New signal processing technologies could play a key role in enhancing outcomes from one of the most important treatments for arrhythmia: catheter ablation. By improving signal clarity, BioSig’s PURE EP™ System has the potential to deliver valuable advances in electrophysiology procedures. The PURE EP™ System is powered by a unique hardware architecture allowing the full range of cardiac analog signals to be acquired in a raw, streamlined, unfiltered format. This is then converted into a digital modality powered by advanced signal processing software for unlimited real time data analysis.

The company recently conducted first clinical cases at the Texas Cardiac Arrhythmia Institute under the leadership of Andrea Natale, M.D., F.A.C.C., F.H.R.S., F.E.S.C., Executive Medical Director, Texas Cardiac Arrhythmia Institute at St. David’s Medical Center. BioSig Technology is working with leading experts and organizations to develop additional features of PURE EP™ and explore signal processing applications in disease areas beyond arrhythmia.